baicalin has been researched along with Polycystic Ovary Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, L; Wang, X; Xu, X | 1 |
| Cui, N; Hao, G; Jiang, L; Wang, W; Zhang, D; Zheng, J; Zhou, H | 1 |
2 other study(ies) available for baicalin and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Baicalin suppress the development of polycystic ovary syndrome via regulating the miR-874-3p/FOXO3 and miR-144/FOXO1 axis.
Topics: Animals; Apoptosis; Cell Proliferation; Female; Forkhead Box Protein O1; Forkhead Box Protein O3; Humans; Mice; MicroRNAs; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley | 2023 |
Baicalin ameliorates polycystic ovary syndrome through AMP-activated protein kinase.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Body Weight; Cytokines; Female; Flavonoids; Hormones; Insulin Resistance; Ovary; Polycystic Ovary Syndrome; Rats, Wistar | 2019 |